These compounds may interact with:
Cyclin-dependent kinase 5 activator 1
Potentially involved in: brain diseases; cognition disorders; nerve degeneration; schizophrenia; adult high grade glioma; astrocytic glioma; astrocytoma, pilocytic; atopic dermatitis; atypical teratoid / rhabdoid tumor; colon cancer; cutaneous lupus erythematosus; ependymoma; esophageal adenocarcinoma; glioblastoma; group 4 medulloblastoma; lung cancer; non primary sjogren syndrome sicca; non-small cell lung cancer; oligodendroglioma; osteosarcoma
Disease data sourced from Pharos.